Considerations in Drug Design

4 weeks ago
Ruslan Pryadun

Drug design is a sophisticated pharmaceutical discipline with a rich history of achievements. Since the late 19th century, when Emil…

Computational Approaches in Drug Discovery

2 months ago

The process of drug discovery is an intricate, expensive, and time-consuming endeavor with a notably low success rate due to…

Late Stage Functionalization in Drug Discovery

4 months ago

A minor functional modification to the structure of a drug candidate can have a profound impact on its biological profile.…

FDA Approved Drugs Using Lipid Nanoparticles Mediated Payload Delivery

7 months ago

Nanomedicine, the field that encompasses the convergence of nanotechnology, pharmaceutical, and biomedical sciences, has experienced rapid advancements in recent years.…

Selective organ-targeting (SORT) lipid nanoparticles for mRNA delivery

7 months ago

Messenger RNA (mRNA) possesses extensive clinical potential for a range of therapeutic applications including vaccination, protein replacement, gene editing, immunotherapies,…

Drug Development via Kinase Targeting

7 months ago

Kinases are enzymes that catalyze the transfer of a phosphate group from adenosine triphosphate (ATP), a high-energy phosphate-donating molecule, to…

Artificial Intelligence in Drug Discovery

9 months ago

Artificial intelligence (AI) is currently drawing increased attention in many aspects of science and technology. AI is the simulation of…

A Promising Approach to Drug Discovery via Molecular Glue Induced Targeted Protein Degradation

9 months ago

Targeted protein degradation (TPD) using small molecules termed as molecular glues (MGs) is potential to explore drug discovery and development…

Proteolysis-Targeting Chimeras (PROTACs) in Cancer Therapy

2 years ago

Proteolysis targeting chimeric (PROTAC) technology is a recently discovered technique that has profound efficacy in cancer. This approach was first…

The Importance of Synthetic Organic Chemistry in Drug Discovery

3 years ago

In recent years, many pharmaceutical companies have chosen to reduce their R&D investment in chemistry, viewing synthetic chemistry more as…